Molecular Predictors of Lung Cancer Behavior
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other, Procedure, Genetic
Study Type: Observational
SUMMARY
RATIONALE: Using samples of blood, urine, sputum, and lung tissue from patients at high risk of cancer for laboratory studies may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is looking at molecular predictors of cancer in patients at high risk of lung cancer.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• All adults referred to Vanderbilt Medical Center, Veterans Administration Medical Center, St. Thomas Hospital and Meharry Medical Center for evaluation of signs or symptoms of lung cancer.
Locations
United States
Tennessee
Vanderbilt-Ingram Cancer Center
RECRUITING
Nashville
Veterans Affairs Medical Center - Nashville
RECRUITING
Nashville
Contact Information
Primary
Vanderbilt Ingram Clinical Trials Information Program
1-800-811-8480
Time Frame
Start Date: 2003-12
Estimated Completion Date: 2025-01-31
Participants
Target number of participants: 4000
Treatments
Sample Collection
Related Therapeutic Areas
Sponsors
Leads: Vanderbilt-Ingram Cancer Center
Collaborators: National Cancer Institute (NCI)